Clinical Trials Browser

Completed × Pancreatic Neoplasms × ruxolitinib × Clear all

NCT05440942 2025-06-05

Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

NCT01423604 2018-02-12

RECAP

Phase 2 Completed

136 enrolled 19 charts

Gastrointestinal

Pancreatic Neoplasms